Oil stock Transocean LTD (NYSE:RIG) is higher yet again today, boosted by crude oil prices. The shares were last seen up 0.4% at $15.48 after notching a fresh annual high of $16.66 earlier in the session. RIG continues to be one of the top post-election performers on the S&P 500 Index (SPX), so far extending its gains since Election Day -- just over one month ago -- to more than 57%. Despite an outstanding run up the charts, RIG remains surrounded by a surprising amount of pessimism.

Beginning with the brokerage bunch, 18 analysts currently rate RIG a "hold" or a "strong sell," compared to just three "strong buy" recommendations. Plus, the average 12-month price target of $9.85 is seated in line with the stock's Nov. 8 close, and thus at a huge discount to current levels. That means RIG may be overdue for a round of upgrades and/or price-target hikes, which could boost the shares.

Short sellers have continued to pile onto the stock in recent weeks, despite the shares' continued climb, setting up a potential short-squeeze situation. During the two most recent reporting periods, these bearish bets grew by 5.5%, and now represent about 27% of RIG's available float. At the equity's average pace of trading, it would take at least six sessions to cover all the shorted shares -- plenty of buying power to give RIG a lift.

Turning to the options pits, bearish bets continue to be the norm, as well. Across the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the stock's 10-day put/call volume ratio of 1.10 sits higher than 70% of the past year's readings. At the same time, it's possible put buyers could be Transocean shareholders protecting paper profits.

No matter the case, this preference for puts is echoed among short-term traders, as well. In fact, RIG's Schaeffer's put/call open interest ratio (SOIR) of 1.82 rests in the high 91st percentile of its annual range. What's more, the stock's front-month, gamma-weighted SOIR sits at 2.48 -- indicating put open interest more than doubles call open interest among near-the-money options in the December series, which expires at the close this Friday.

Today RIG puts are changing hands at nearly double the expected intraday rate, with over 33,000 on the tape so far. It appears some bearish speculators may be buying to open the December 14 and 14.50 puts. Buyers of these puts are betting RIG shares will drop back below the respective strike prices before the end of the week. Meanwhile, the largest single trade involved a block of 10,000 January 2018 10-strike puts, which may have been bought to open as long-term protection, as Trade-Alert indicates the block is tied to 160,000 shares of RIG stock.

On either side of the tape, short-term options buyers could be getting a great deal on RIG. The security's 30-day at-the-money implied volatility of 50.2% and its Schaeffer's Volatility Index (SVI) of 48% are seated in the low 4th and 6th percentiles of their respective 12-month ranges. Simply stated, the stock's near-term options are pricing in historically low volatility expectations at the moment.

As alluded to, since Election Day, RIG stock has accomplished some impressive technical feats. After a bounce off the familiar $11 level, the shares flew into positive year-to-date territory for the first time since July -- and now sit on a 25% lead for 2016. What's more, Transocean LTD (NYSE:RIG) is on pace for a sixth consecutive daily win.

Let us help you profit from market volatility. Target big gains in short order with a 30-day trial of Schaeffer's Weekly Volatility Trader!

Analysts are weighing in on oil-and-gas stock Whiting Petroleum Corp (NYSE:WLL), biotech Regeneron Pharmaceuticals Inc (NASDAQ:REGN), and chipmaker Advanced Micro Devices, Inc. (NASDAQ:AMD). Here's a quick roundup of today's bullish brokerage notes on WLL, REGN, and AMD.

• WLL is set to pop 8% at the open, as crude oil prices explore annual-high territory. Also boosting shares of Whiting Petroleum Corp is a price-target hike to $13 from $9 at Wunderlich. The stock is up roughly 29% year-to-date based on last week's settlement at $12.14, and has recently found a solid foothold above the $12 mark. Options traders seem to be eyeing more gains, too. WLL's 10-day call/put volume ratio at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) stands at a top-heavy 5.54 -- higher than 91% of all readings from the past 12 months, suggesting calls have been bought to open over puts at an accelerated clip in recent months.
  
  
• REGN is up 4.1% ahead of the bell, following an upgrade to "neutral" from "sell" at Chardan Capital, which also raised its price target on the stock to $350 from $300. Also creating a boon for REGN is news competitor Ophthotech Corp's (NASDAQ:OPHT) combination treatment for age-related macular degeneration failed to meet its primary endpoint in a late-stage trial. According to an analyst from RBC, the results mean that Regeneron Pharmaceuticals Inc's drug, Eylea, should remain the standard treatment for the disease. It's been a rough year for REGN, though, off 31% to close Friday at $372.83 -- so, it's little surprise analysts have largely been skeptical. In fact, of the 17 brokerage firms tracking the shares, 11 rate them a "hold" or worse. 
  
  
• AMD could make another run at nine-year highs today -- up 1.8% in electronic trading -- after BMO raised its rating on the stock to "outperform" from "market perform" and more than doubled its price target, to $15 from $6. At $10.34, shares of Advances Micro Devices, Inc. have tacked on an incredible 260% in 2016 -- and tagged $10.66 last Thursday, their highest mark since November 2007. And while analysts are slowly beginning to raise their opinions, nearly 12% of AMD's available float remains tied up in short interest. This could create a short-covering situation, which may give the outperforming stock an additional boost. 

Don't miss the market's next move! Sign up now for Schaeffer's Midday Market Check.

U.S. stock futures are trading below fair value this morning, despite a huge rally in oil prices. Among specific equities in focus today are biotech stocks Ophthotech Corp (NASDAQ:OPHT), Achaogen Inc (NASDAQ:AKAO), and Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). Here's a quick look at what's driving OPHT, AKAO, and ALXN.

• OPHT is looking at an 82% sell-off when the market opens, after the company's vision-loss treatment failed to reach its goals in two phase 3 trials. The shares will now open in all-time-low territory below the $7 mark. For reference, Ophthotech Corp started the year near the $80, and closed Friday at $38.77. So far SunTrust Robinson weighed in with a downgrade to "hold" from "buy," and a price-target cut to $7 from $100, while Chardan Capital lowered its rating to "neutral" from "buy." More bearish analyst notes now seem likely, since all nine brokerage firms covering the stock considered it a "buy" or "strong buy" as of Friday's close. 

• News that its primary antibiotic, plazomicin, succeeded in two keys studies has shares of AKAO up 43.1% in pre-market trading. The drug company now plans to submit marketing materials to U.S. and European regulators late next year and early 2018. The pending move would put the stock at an annual high, after closing Friday slightly below its year-to-date breakeven point at $5.25. Short-term options traders, however, appear ill-prepared for such a move. Achaogen Inc's Schaeffer's put/call open interest ratio (SOIR) of 1.70 is a 12-month high, meaning options traders targeting contracts expiring within three months are the most put-skewed they've been in a year. 

• ALXN is set to drop over 13% this morning, following news the company's CEO and CFO have stepped down amid its internal accounting probe. David Brennan will take over as interim CEO, while David Anderson will step in as CFO. At $132.07, ALXN had shed almost 31% in 2016, but it seems a number of short sellers will miss today's slide. For instance, short interest on Alexion Pharmaceuticals, Inc. declined by 19.4% during the last two reporting periods. 

Stay on top of overnight news & big morning movers. Sign up now for Schaeffer's Opening View.

The S&P 500 Index (SPX) notched its sixth straight daily win last Friday -- a first for the broad-market barometer since June 2014. With the SPX also fresh off a record closing high, stocks are trading lower this morning as oil prices skyrocket -- while history suggests a seventh consecutive positive day for the S&P is rare. In fact, according to Schaeffer's Senior Quantitative Analyst Rocky White, the S&P 500 Index has been positive just 25% of the time on the seventh day following a six-day winning streak since the 2009 bottom, and has averaged a loss of 0.2%.

The action has historically been pretty choppy going forward, too, per the chart below. Looking out one week after the S&P 500's six-day win streak, the index has averaged a return of 0.6%, and has been positive three-quarters of the time. This is better than the SPX one-week average anytime return of 0.3%, and "percent positive" of 59.6%.

Since 2009, the SPX has historically left its post-streak outperformance at one week, though. Specifically, when looking at the two-week return, the S&P 500 Index (SPX) has averaged a gain of 0.3%, versus an anytime return of 0.6% -- although the index is positive 68.8% of the time post-streak, versus 62.2% anytime. This historical underperformance is even more notable at one month, when the SPX has averaged a post-streak return of just 0.03%, versus an anytime return of 1.2%.

Let us help you profit from market volatility. Target big gains in short order with a 30-day trial of Schaeffer's Weekly Volatility Trader!

Analysts are weighing in on tech stock Synaptics, Incorporated (NASDAQ:SYNA), drugmaker Depomed Inc (NASDAQ:DEPO), and gold concern Gold Fields Limited (ADR) (NYSE:GFI). Here's a quick roundup of today's bearish brokerage notes on SYNA, DEPO, and GFI.

• A downgrade to "underperform" from "perform" at Oppenheimer has SYNA down 2.5% at $54.99 this morning, widening its year-to-date deficit to 31.6%. The brokerage firm explained, "market and customer demands are not in favor of SYNA." The stock has spent the past month running into trouble in the $55-$58 range, which served as support throughout September. Meanwhile pessimism toward the equity has been building. During the most recent two-week reporting period, short interest on Synaptics, Incorporated climbed nearly 27%. These bearish bets now represent 12.6% of SYNA's available float, or more than a week's worth of trading, at the stock's average daily volume. 
  
  
• DEPO saw its rating cut to "underweight" from "neutral" at Piper Jaffray, sending the stock sliding 9% to $18.38 -- and landing it on the short-sale restricted list. Depomed Inc is now up less than 2% in 2016, and testing recent support in the $18.50 region. While options volume on the stock tends to run light on an absolute basis, speculators have been taking an extremely call-skewed approach in recent weeks. Specifically, DEPO's 10-day call/put volume ratio at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) clocks in at a top-heavy 83.52 -- just 5 percentage points from an annual high. 
  
  
• RBC lowered its rating on GFI to "sector perform" from "outperform," but the stock is up 2.1% at $2.96. That said, GFI has been sliding down the charts for months, dropping 55% from its August three-year high of $6.60. In the options pits, call buying remains popular on an absolute basis. And bears may be backing off elsewhere -- short interest on Gold Fields Limited (ADR) dropped by 13% during the most recent reporting period to account for just 0.4% of the stock's total float. 

Find out where the Dow lands right after the closing bell. Sign up now for Schaeffer's Market Recap

Aerospace issue Lockheed Martin Corporation (NYSE:LMT) is just the latest stock moving on a tweet from President-elect Donald Trump. Specifically, Trump took to Twitter Inc. (NYSE:TWTR) to say LMT's "F-35 program and cost is out of control" -- echoing last week's critical tweet of Boeing Co's (NYSE:BA) Air Force One program -- sending LMT stock down 3.8% to trade at $249.55. Amid today's pullback, LMT options volume has exploded to five times the average intraday pace -- with 4,545 puts traded at last check, compared to 4,484 calls.

Today's put-skewed trading just echoes the withstanding trend seen among short-term traders in LMT's options pits, per the stock's Schaeffer's put/call open interest ratio (SOIR) of 2.07. Not only does this show that puts more than double calls among options set to expire in three months or less, but it ranks in the elevated 93rd annual percentile.

However, the SOIR measures a stock's total open interest -- and includes contracts that were both bought and sold. According to the major options exchanges, LMT traders have shown a penchant for short puts in recent weeks. Specifically, speculators at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) have sold to open 2.01 puts for each one they've bought over the past 20 sessions.

Outside of the options pits, short interest jumped 35% in the most recent reporting period. Nevertheless, these bearish bets account for just 1% of the LMT's available float -- and the 2.6 million shares sold short are a far cry from the 36.8 million in mid-August. Meanwhile, analysts are mostly upbeat, with the stock seeing seven "strong buy" recommendations, versus four "holds" and not a single "sell."

Looking at the charts, the stock has put in a standout performance in 2016, up almost 15%. Plus, the stock topped out at a record high of $269.90 one week ago. What's more, today's retreat is being contained by Lockheed Martin Corporation's (NYSE:LMT) 80-day moving average -- a trendline that worked as resistance earlier this year, but could now be switching to a more supportive role.

Sign up now for Schaeffer's Market Recap to get all the day's big stock movers, must-know technical levels, and top economic stories straight to your inbox.

Payment processor VeriFone Systems Inc (NYSE:PAY) is due to report fiscal fourth-quarter earnings after the close this evening. Heading into the event, the stock is down 0.2% at $16.42, and options traders seem to be bracing for a post-earnings sell-off. Given PAY's recent post-earnings history, however, that's hardly surprising.

Over the past eight quarters, PAY stock has averaged a one-day swing of 7.8% in either direction the session after earnings, moving higher on four occasions. But the last two quarters saw the stock plunge 16.4% and 24.7% lower in the post-earnings sessions. Perhaps that's why the options market is currently pricing in a hefty 18.2% move for Tuesday.

Meanwhile, the equity's puts are popular today, trading at six times the expected intraday pace, outnumbering calls in the process. In fact, put volume is running in the 98th percentile of its annual range. Buyers of near-term PAY options are likely forking over some hefty premiums today, too, considering the stock's 30-day at-the-money implied volatility is parked at a 12-month high of 78.4%.

Taking a step back, options traders have been picking up PAY puts over calls at an unusual rate in recent weeks. At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the stock's 10-day put/call volume ratio of 0.84 ranks higher than 77% of all comparable readings taken in the past year.

There's plenty of skepticism outside of the options arena, as well. Short interest on PAY edged up by 7.8% during the last two reporting periods, and now accounts for 9.3% of the security's available float. At average daily trading volumes, it would take about a week for short sellers to cover their bearish positions. Plus, 13 of the 19 analysts tracking PAY rate the stock a lukewarm "hold," with J.P. Morgan Securities lowering its price target to $17 from $20 just this morning.

It's not only the stock's earnings history that has inspired these pessimistic points of view, either. VeriFone Systems Inc (NYSE:PAY) has given up 41% of its value so far in 2016, and has been hitting a series of lower lows since mid-2015. The shares have been slumping under pressure from the 80-day moving average over the past week, but they seem to be holding onto support in the $15-$16 region, which has capped the stock's losses since May 2010.

Let us help you profit from market volatility. Target big gains in short order with a 30-day trial of Schaeffer's Weekly Volatility Trader!

Analysts are weighing in on drug stocks Biogen Inc (NASDAQ:BIIB) and AstraZeneca plc (ADR) (NYSE:AZN), as well as Apple Inc. (NASDAQ:AAPL) supplier Broadcom Ltd (NASDAQ:AVGO). Here's a quick roundup of today's bullish brokerage notes on BIIB, AZN, and AVGO.

• BIIB is up 5% ahead of the bell after promising results from a study of the company's Alzheimer's treatment were released late Thursday. The news earned Biogen Inc price target hikes at Baird and Stifel -- to $309 and $298, respectively. The stock is off 5.5% year-to-date at $289.54, but the shares appear to have found a foothold above the historically significant $285 level. Meanwhile, analysts are already largely in BIIB's bullish corner, with 12 out of 16 rating the equity a "buy" or better, and not a single "sell" opinion on the books.
  
  
• AZN is set to tack on 1.5% at the open on news the company will expand its collaboration with Eli Lilly and Co (NYSE:LLY) on Alzheimer's research. Separately, AZN announced encouraging results on cancer drug Tagrisso. On the brokerage front, Leerink upgraded its rating on AZN to "outperform" from "market perform," even though the stock tapped a three-year low just days ago. In fact, the shares have been falling hard since late September, bringing their 2016 deficit to 22.6%, at $26.27. But that hasn't stopped options traders from picking up bullish bets. At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), AstraZeneca plc's top-heavy 10-day call/put volume ratio of 32.33 sits in the 87th percentile of its annual range. 
  
  
• AVGO is on track to notch a new record high at the open, up 6.3% in pre-market trading, after the company reported strong earnings and an upbeat outlook, while also doubling its dividend. While 26 of 27 analysts already recommend buying AVGO shares, at least 11 brokerage firms raised their price targets on the stock, with every one of them setting a target at or above the never-explored $200 mark. B. Riley offered the highest target price of all, at $235 -- a 37.7% premium over last night's close at $170.71. Despite Broadcom Ltd's promising technical setup, there may not be much buying power left on the sidelines to keep the rally alive for long. 

Don't miss the market's next move! Sign up now for Schaeffer's Midday Market Check.

U.S. stocks are looking to keep their winning streak alive, with the major benchmarks trading higher out of the gate. Among specific equities in focus today are fiber optics specialist Finisar Corporation (NASDAQ:FNSR), cable service provider Charter Communications, Inc. (NASDAQ:CHTR), and casino stock Wynn Resorts, Limited (NASDAQ:WYNN). Here's a quick look at what's driving FNSR, CHTR, and WYNN.

• FNSR is up 4.4% at $35.64 -- fresh off a five-year high of $36.85 -- after the company announced better-than-expected earnings and an upbeat current-quarter outlook. Plus, Craig-Hallum was one of at least seven brokerage firms to lift its price target, raising its mark to $46 from $34. The shares of Finisar Corporation could be prepared to extend today's upside, too, given how skeptical Wall Street has been toward a stock that's up almost 150% year-to-date. As one example, short interest jumped 31% during the past two reporting periods, and now more than a week's worth of buying power is controlled by these bears, at the average pace of trading. If short sellers begin to cover their losing positions, it could help FNSR rise even more. 

• CHTR is 0.1% higher at $279.36, after hedge fund manager Chris Hohn said the shares could double or triple in the years ahead -- and thinks Charter Communications, Inc. could eventually be a takeover target for Verizon Communications Inc. (NYSE:VZ). It's already been a strong year for the stock, after a sharp bounce from its 160-day moving average last month helped guide it to an all-time high of $287.27 just two days ago. Options traders appear to be betting on more upside, too, since call buying has more than tripled put buying during the past two weeks at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). 

• Casino stocks are set to rebound after getting crushed yesterday, after Macau's government denied it would be setting daily limits on ATM withdrawals -- although limits for each individual transaction will be contained.  WYNN, for example, is trading 4.7% higher at $94.73, although the stock is still well below the $100-$105 range that's limited its upside since April. Analysts don't seem too hopeful, either. Just four of 14 covering brokerage firms currently recommend buying Wynn Resorts, Limited. 

Stay on top of overnight news & big morning movers. Sign up now for Schaeffer's Opening View.

Analysts are weighing in on biotech issue Horizon Pharma PLC (NASDAQ:HZNP), retail stock Restoration Hardware Holdings Inc (NYSE:RH), and copy expert Xerox Corp (NYSE:XRX). Here's a quick roundup of today's bearish brokerage notes on HZNP, RH, and XRX.

• HZNP is up 1.3% at $15.23, even after Mizuho cut its rating on the stock to "neutral" from "buy," and its slashed its price target to $14 from $30. BMO also lowered its price target on Horizon Pharma PLC, to $24 from $29. The stock seems to be getting a small bounce after surrendering 22.5% on Thursday following ugly drug data, but HZNP short sellers are hoping the sell-off will continue. At the moment, more than 11% of HZNP's available float is wrapped up in these bearish bets. 
  
  
• RH reported third-quarter earnings and revenue above analyst estimates, but a lowered current-quarter outlook on concerns of slower holiday sales has the stock spiraling 16.1% to $32.72. So far Goldman Sachs, Telsey Advisory Group, and UBS have chimed in with price-target cuts, the latter setting the lowest bar, at $37. Restoration Hardware Holdings Inc has given back more than 62% of its value year-over-year, but options traders have been betting on a comeback. Specifically, the stock has seen nearly three calls bought to open for each put over the past 10 weeks at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). Moreover, the resulting call/put volume ratio of 2.93 sits in the top quartile of all readings from the last 12 months. 
  
  
• XRX is off 0.4% at $9.48 after a price-target cut to $10 from $11 at J.P. Morgan Securities. Separately, the company's soon-to-be-spun-off Conduent segment said it has entered a credit agreement to purchase international Xerox Corp subsidiaries. XRX has had a choppy year on the charts, lately consolidating around the $9.40 mark. Meanwhile, near-term options trader have been less call-skewed than normal, per the stock's Schaeffer's put/call open interest ratio (SOIR) of 0.69 -- higher than 94% of the past year's readings. What's more, XRX's front-month gamma-weighted SOIR sits at a top-heavy 2.77, indicating put open interest nearly triples call open interest among near-the-money options in the December series. 

Find out where the Dow lands right after the closing bell. Sign up now for Schaeffer's Market Recap

Las Vegas Sands Corp. (NYSE:LVS) is bouncing back following Macau's clarification of its change to ATM withdrawal limits. Specifically, the casino stock has popped 3.3% on heavy volume to trade at $56.47, sparking a flurry of activity in the options arena. Of course, a rebound in the gaming shares may have already been in the cards, considering they settled yesterday with a 14-day Relative Strength Index (RSI) of 33 -- on the verge of oversold territory.

Options traders are likely welcoming the LVS rally with open arms. Calls have been bought to open over puts at a feverish pace in recent weeks at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). The stock's 10-day call/put volume ratio is a top-heavy 4.96 -- in the bullishly skewed 88th annual percentile.

It's more of the same today, with calls outstripping puts, and trading at quadruple the usual intraday rate. Moreover, total options volume is currently running in the 99th annual percentile. Most active is the weekly 12/30 60-strike call, with ISE data confirming at least some buy-to-open activity. In other words, the buyers believe LVS will muscle back atop $60 before the year closes out.

However, not everyone's so confident in the gambling stock. Eight of 13 analysts have hit Las Vegas Sands with a "hold" or a "strong sell" rating. Separately, short interest has been falling on the equity, but 11.4 million shares are still sold short.

This skepticism comes despite LVS' impressive long-term performance. Year-to-date, the shares have soared to a nearly 30% gain. From a contrarian perspective, today's resumption of this upward trend could trigger a round of upgrades and/or a continuation in short covering -- potentially bolstering a move higher.

That said, those looking to purchase premium on short-term Las Vegas Sands Corp. (NYSE:LVS) options are likely to pay a pretty penny. The casino stock's Schaeffer's Volatility Index (SVI) is 56%, outranking four-fifths of all readings from the prior year. In other words, higher-than-usual volatility expectations are currently being priced in to front-month options.

Sign up now for Schaeffer's Market Recap to get all the day's big stock movers, must-know technical levels, and top economic stories straight to your inbox.

The Trump rally rolled on, with the Dow, S&P 500 Index (SPX), and Nasdaq Composite (COMP) all scoring fresh record highs this week -- and the Dow leaving a critical level in the dust. In fact, President-elect Donald Trump's Twitter Inc. (NYSE:TWTR) account seemingly served as a puppeteer for the stock market. Specifically, Dow stock Boeing Co (NYSE:BA) took a tumble on Tuesday, after Trump posted a criticizing tweet over the cost of the Air Force One program. Elsewhere, shares of Twitter and Sprint Corp (NYSE:S) made big moves of their own, as Trump's tweet over a potential $50 billion investment from Japan's SoftBank sparked buyout buzz for the two companies.

Outside of Twitter, Trump's comments over drug pricing in Time's "Person of the Year" cover story sent biotechs tumbling on Wednesday -- putting several overloved drug stocks on notice. And while Citron Research called this company "the culprit behind pharmaceutical price gouging" and Puma Biotechnology Inc (NYSE:PBYI) plunged on downbeat drug data, not all news was bad for biotechs. In fact, shares of SAGE Therapeutics Inc (NASDAQ:SAGE) and Neuroderm Ltd (NASDAQ:NDRM) surged on well-received updates for their respective treatments for postpartum depression and Parkinson's disease.

Elsewhere, bank stocks continued to shine in the post-Trump era, with the Financial Select Sector SPDR ETF (XLF) boasting a 4% week-to-date lead at last check. This positive price action was echoed in Bank of America Corp (NYSE:BAC) -- which started the week off with some love from the brokerage bunch -- and JPMorgan Chase & Co. (NYSE:JPM), with shares of both big banks notching new highs this week. And while regional bank Regions Financial Corp (NYSE:RF) followed its more well-publicized cohorts higher, this underloved bank stock could be a proverbial diamond in the rough for contrarian traders.

Not to be outdone, tech stocks saw their fair share of action throughout the week, with chipmakers seeing the bulk of the upside. Apple Inc. (NASDAQ:AAPL) supplier Broadcom Ltd (NASDAQ:AVGO), for instance, seems set to close out the week at record highs, thanks to a positive earnings reaction. Micron Technology, Inc. (NASDAQ:MU) also notched a notable milestone -- before taking an expected breather in Friday's trading. Elsewhere in the tech sector, Amazon.com, Inc. (NASDAQ:AMZN) unveiled its first foray into the brick-and-mortar grocery business, rumors swirled over a potential Apple takeover of streaming giant Netflix, Inc. (NASDAQ:NFLX), Facebook Inc (NASDAQ:FB) could be facing more legal headaches overseas, and Barron's was quite impressed with Alphabet Inc (NASDAQ:GOOGL). Amid these headlines, "FANG" stocks followed the COMP higher, with all four on pace to log weekly wins.

With markets raging higher, though, several sentiment indicators we follow are reaching extreme levels of optimism. Schaeffer's Senior Quantitative Analyst Rocky White specifically ran the numbers of the massive build in SPX buying climaxes and the recent spike in bullishness among financial advisors, with both signals suggesting near-term headwinds could be on the horizon.

Nevertheless, at last check, the Dow was up 2.4% week-to-date, while the SPX and COMP were boasting week-to-date leads of 2.7% and 3.5%, respectively. What's more, the Russell 2000 Index (RUT) continues to outperform, up 5.7% since last Friday's close. Looking ahead, next week could certainly be a volatile one, with the December Fed meeting on tap -- and expectations high that the central bank is poised to pull the trigger on its first interest rate hike in a year.

Schaeffer's Expiration Week Countdown subscribers just made 100% GAINS on Amazon.com (AMZN) calls! Sign up now for a trial subscription.